Trial Profile
Follow-Up Study of Safety of Pneumostem in Premature Infants With Intraventricular Hemorrhage
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Cerebral haemorrhage
- Focus Therapeutic Use
- 07 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2023.
- 07 Apr 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2022.
- 16 Feb 2016 New trial record